Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Dysfibrinogenemia, Congenital MeSH Supplementary Concept Data 2025


MeSH Supplementary
Dysfibrinogenemia, Congenital
Unique ID
C562727
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C562727
Registry Numbers
0
Heading Mapped to
*Afibrinogenemia
Frequency
63
Note
A hereditary, usually autosomal dominant disorder that affects the quality of circulating FIBRINOGEN. About half of patients are asymptomatic, and half have an increased tendency for bleeding, THROMBOSIS, or both. Mutations in the FGA and FGB genes have been identified. OMIM: 616004
Date of Entry
2012/11/05
Revision Date
2015/08/18
Dysfibrinogenemia, Congenital Preferred
page delivered in 0.004s